Imunon Inc

+0.03 (+1.88%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)11.57M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.11 Million
Adjusted EPS-$0.90
See more estimates
10-Day MA$1.85
50-Day MA$2.20
200-Day MA$4.13
See more pivots

Imunon Inc Stock, NASDAQ:IMNN

997 Lenox Drive, Suite 100, Lawrenceville, New Jersey 08648
United States of America
Phone: +1.609.896.9100
Number of Employees: 29


Imunon, Inc. is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm engages in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.